Dawn Bell on Smart Risk
Dr. Dawn Bell is the Global Development Head, Strategic Partnerships at Novartis, a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Novartis - one of the largest pharmaceutical companies in the world - is where Dawn leads business development and portfolio strategy for whitespace opportunities. Working in large pharma, mid-sized, and start-up companies, she has developed and launched 12 innovative medicines across 8 therapeutic areas. Dawn is energized by working with and advising founders and start-up CEOs through her role as a Mentor at Creative Destruction Lab, and Executive Council member in EIT Health’s Gold Track Program (Germany). She serves as a board advisor to two privately held, venture-backed drug discovery companies and board director for The Metabolomics Innovation Center, a nationally funded research facility based in Alberta, Canada.
Connected Intelligence with Sonia Sennik
Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.